Clinical Trials Browser

Interventional × Maximum Tolerated Dose × 90 days × Clear all

NCT05976555 2026-05-20

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Phase 1 Not yet recruiting

Multiple Myeloma

NCT03663218 2026-03-18

PREPARE SBRT

Phase NA Active not recruiting

16 enrolled 9 charts

Prostatic Neoplasms